Dr Alan Lamont
Dr. Alan Lamont has been engaged in Corporate and Business Development roles for various companies over the past 20 years, including Acambis (UK/US), AstraZeneca (UK), Eli Lilly (UK/US) and latterly with Mundipharma International Ltd. based in Cambridge, UK. During this time, he has executed deals and established partnerships with a large number of external partners, ranging in type from early, pre-clinical stage, R&D collaborative partnerships, in-licensing/acquisition of clinical stage programmes, through to commercial deals involving on-market products. In his roles at Acambis and Mundipharma, he has also gained significant experience in corporate M&A. He currently also serves as a Non-Executive Director for Synpromics Ltd. (Edinburgh, U.K.).